Catalyst Wire Dossier Catalyst Wire Dossier

bupropion extended-release 150 mg tablets

bupropion hydrochloride extended-release · Actavis Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for bupropion extended-release 150 mg tablets, covering 2010-08-16 to 2010-08-16. Get the full timeline:

Most recent: Clinical Trial Update: A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting Conditions [Phase 1]

See pricing